ONO-1301

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameONO-1301
Drug Alias NameONO-1301-PLGAONO-AP-50002ONO-1301SRONO-1301MSOno-1301 +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 synthase inhibitorsProstanoid IP receptor agonists
TargetsThromboxane A2 synthaseProstanoid IP receptor
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOno Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOno Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A